Peptides DB
Research-centric peptide and protocol reference hub
Study 14 of 26Kisspeptin (KP-10) literatureHuman vaccines & immunotherapeutics2026

Reduced T cell epitope cross-conservation and immunogenic potential is associated with emergence of a dominant influenza subclade K in 2025.

A 10% reduction in T cell epitope conservation may impact the efficacy of vaccines against the dominant influenza subclade K.

Read at Human vaccines & immunotherapeuticsAdd to compare

Where it sits

this study against the rest of the kisspeptin (kp-10) corpus
1
Preclinical · this one
21
Observational
0
Open-label
3
Randomised
1
Reviews

Summary and findings

This study assessed T cell epitope cross-conservation in the newly emergent influenza subclade K compared to other H3N2 strains and seasonal vaccines. A 10% reduction in cross-conserved T cell epitope content was observed. The findings suggest implications for vaccine efficacy against subclade K.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
10% reduction in cross-conserved T cell epitope content.2026

Abstract

The authors’ words, as Human vaccines & immunotherapeutics supplied them

Subclade K is a newly emergent influenza A/H3N2 strain that became the dominant strain circulating globally; more than 90% of influenza A virus (IAV) cases in 2025-26 were subclade K. While seasonal vaccines elicited measurable cross-reactive hemagglutination inhibition (HI) and neutralizing antibody responses against the new strain were deemed to be protective, T cells contribute substantially to protection against infection and severe disease. T cell epitopes that are conserved between vaccine strains and circulating strains may have a protective effect. We hypothesized that mutations in the HA antigen introduced by viral evolution resulted in the loss of some cross-conserved T cell epitopes and that this loss may have contributed to the emergence of subclade K. Using a new immunoinformatics tool, EpiCC, we assessed T cell epitope cross-conservation between subclade K, other circulating H3N2 strains, and the most recent seasonal vaccine strains. Evaluation of 706 H3N2 HA sequences demonstrated a 10% reduction in cross-conserved T cell epitope content between seasonal vaccines, circulating strains and subclade K. Decreased cross-conservation may signal the emergence of new flu strains. Proactive analysis of cross-conserved T cell epitopes may improve vaccine selection. Loss of T cell epitopes could also reduce the efficacy of new subclade K influenza vaccines in fall 2026.

Elsewhere in the Kisspeptin (KP-10) corpus

C<i>Kiss1</i> neurons in the medial amygdala of mice are sexually dimorphic and unique from hypothalamic anteroventral periventricular <i>Kiss1</i> neurons in their action potential firing propertiesbiorxiv-preprint · 2026 · Not reported in abstract.AnimalBDifferentiation of KISS1-Expressing Cells from Human Pluripotent Stem Cells: Many Roads To Romebiorxiv-preprint · 2026 · Not reported in abstract.In vitroBClinical immunogenicity and pharmacokinetic assessments of E3112, a recombinant human hepatocyte growth factor.Future science OA · 2026 · Half-life of 19.3 h.HumanCT cell-associated immunity induced by heterologous recombinant BCG and purified protein vaccination confers cross-variant protection against SARS-CoV-2.Human vaccines & immunotherapeutics · 2026 · Not reported in abstract.AnimalBDay-to-day variability in resting metabolic rate in strength athletes.Journal of the International Society of Sports Nutrition · 2026 · n=13 · Mean RMR was 26.9 ± 1.4 kcal·kgFFM⁻¹·day⁻¹ in males and 29.1 ± 1.7 kcal·kgFFM⁻¹·day⁻¹ in females.HumanCDevelopment and characterization of a topical ferrochelatase inhibitor nanoemulsion for choroidal neovascularization therapy.International journal of pharmaceutics: X · 2026 · Reduction in L-CNV by >45% compared to blank NEs.Animal